Not to jump on the ramping wagon.
But given IMU seem to present at conferences all the time without ASX announcements. And this announcement has been flagged as price sensitive. It makes sense to me some new bile duct trial data is going to be presented, and it's likely going to be very positive news.
DYOR not advice.
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-14
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.002(2.82%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.1¢ | 6.9¢ | $747.5K | 10.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1363554 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 1130620 | 10 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.002 ( 1.15 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 6.9¢ | 3175836 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| IMU (ASX) Chart |